Cancer BiologybioRxivPreprint
Spliceosomic dysregulation unveils NOVA1 as an actionable therapeutic target in pancreatic neuroendocrine tumors
S. Pedraza-Arevalo, E. Alors-Perez, R. Blazquez-Encinas…·J. P. Castano
The paper identifies NOVA1 as a therapeutic target in PanNETs by showing its role in splicing dysregulation, cell proliferation, and drug resistance.
DOI 10.1101/2022.02.09.479525